Ata, Baby Girl .
HRN: 29-06-90 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/28/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
05/28/2026
06/04/2026
IV
24mg
Q36H
NEONATAL SEPSIS
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines